{"brief_title": "Inhaled Corticosteroid Replacement Study - Efficacy and Safety of Ro 27-2441 (Test Drug) in Moderate Persistent Asthma", "brief_summary": "The primary objective of the study is to evaluate the anti-inflammatory action and safety of Ro 27-2441 (study drug) in asthmatic patients currently taking inhaled corticosteroids. The research is being conducted at up to 40 clinical research sites in the US. Study participants will have a number of visits to a research site over a 4-month period.", "condition": "Asthma", "intervention_type": "Drug", "intervention_name": "Dual Integrin Antagonist", "criteria": "Inclusion Criteria: - Persistent asthma for more than 1 year - Currently receiving treatment with a stable dose of inhaled corticosteroids for more than 3 months - In good health as demonstrated by medical history and physical exam - Negative urine pregnancy test - Commitment to use two forms of effective contraception simultaneously throughout the study duration and for 1 month after discontinuing therapy Exclusion Criteria: - Hospitalization for treatment of asthma and/or treatment with oral/injectable corticosteroids within 3 months before the start of the study - Undergoing allergy shots unless on a stable maintenance dose for 3 months before the start of the study - History of chronic pulmonary diseases other than asthma - Treatment of conditions other than asthma with oral corticosteroids within 1 month of the start of the study - Current tobacco usage - Smoking history of greater than 10 pack-year history of cigarette smoking (number of packs smoked per day times the number of years smoked) - History or evidence of drug or alcohol abuse - Diagnosis or evidence of an infectious illness within one month of Visit 1 - Clinically significant diseases as assessed by the study doctor - Participation in another clinical study with an experimental drug within one month of start of the study", "gender": "All", "minimum_age": "18 Years", "maximum_age": "70 Years", "healthy_volunteers": "No", "id": "NCT00048022.xml"}